Danning tablets have been successfully exported to Canada and entered the international mainstream drug market

10 (UPI) - Chinese medicine gall tablets have been officially delivered to Toronto, Canada. This means that Tylenol tablets have officially entered the international mainstream drug market.

Bile ning tablets production enterprises - Shanghai and yellow pharmaceutical chose - traditional medicine herbs - "pharmacopoeia pharmacopoeia varieties, based on domestic evidence" of the registered path, after 15 months, nearly 100 registered declare information preparation, writing and translation, and after many times communication with health Canada, in September 2016, enterprise formally submitted to health Canada registration, And a one-time through the expert review, official publicity and other approval processes.

On December 15, 2016, Danning Tablet obtained the marketing license of Natural Medicine in Canada (NPN: 80073325). On July 12, 2019, Shanghai Hehuang Pharmaceutical obtained the certification of production site outside Canada, becoming a Chinese traditional medicine manufacturer granted the FSRN certificate (FSRN: 5000525) by Health Canada. Previously, in October 2018, experts from the Ministry of Health of Canada came to China for an academic exchange and inspected the manufacturing site of Danning tablets at Shanghai Hehuang Pharmaceutical. Experts praised the conditions of the modern production site for the tablets as "Amazing".

In 2022, the company signed a three-year sales agreement with imports in Canada. In July, the two sides signed a contract for the export of the first batch of choline tablets.

Zhou Junjie, president of Shanghai Hehuang Pharmaceutical, said at the loading and delivery ceremony of Danning tablets for export to Canada that over the years, the company has been adhering to the application of scientific exploration, interpretation of the clinical value of traditional Chinese medicine, and strive to achieve the goal of modernization and internationalization of traditional Chinese medicine. Now the phased targets have finally been met. In the future, Shanghai Hehuang Pharmaceutical will continue to inherit the classics, maintain innovation and make new contributions to the modernization and internationalization of traditional Chinese medicine.